Studies on amidotrizoate therapy in sudden deafness (1978-1987).
The therapeutic effects of amidotrizoate in 47 sudden deafness patients from 1978 to 1987 were studied. The therapeutic results were investigated in terms of each of four variables: time from onset, degree of hearing loss, type of audiogram, and vertigo. Results showed that patients who had no vertigo, and were treated within 1 week of onset had satisfactory results. The degree of hearing loss did not influence recovery, although, all those with total loss type according to audiogram remained unchanged. Twenty-four of 34 cases (71%) treated within 2 weeks showed either complete or marked recovery; this proportion was not much different from the results in our previous investigations.
Ushisako
Y
Y
Department of Otorhinolaryngology, Miyazaki Medical College, Japan.
Morimitsu
T
T
D000293:Adolescent; D000328:Adult; D000368:Aged; D001301:Audiometry, Pure-Tone; D001309:Auditory Threshold / Q000187:drug effects; D003973:Diatrizoate / Q000008:administration & dosage*; D005260:Female; D005500:Follow-Up Studies; D003639:Hearing Loss, Sudden / Q000188:drug therapy*; D006801:Humans; D007262:Infusions, Intravenous; D008297:Male; D008875:Middle Aged
D003973:Diatrizoate